🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
At present, there is no standard second-line treatment of refractory and re...
Status
Unknown
Location
he First Affiliated Hospital of Guangzhou Medical College
Start Date
2012-10
Trial ID
NCT01872416
Treatments Being Tested
This is a Phase II pilot study of chemotherapy and surgery for children wit...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
1997-10
Trial ID
NCT00186849
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Lund University Hospital
Start Date
1996-04
Trial ID
NCT00002764
Treatments Being Tested
Apatinib mesylate is a multitarget receptor tyrosine kinase inhibitor. This...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-08-20
Trial ID
NCT04012827
Treatments Being Tested
BICHE- 1: Brain Irradiation for Childhood cancer - Endocrine monitoring dur...
Status
Recruiting
Location
CHU Angers
Start Date
2025-10-10
Trial ID
NCT06618703
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Tulane Cancer Center at Tulane University Hospital and Clinic
Start Date
2001-10
Trial ID
NCT00028860
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
Primary Objective: -To evaluate the feasibility and efficacy of multimodal...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
1999-08
Trial ID
NCT00512096
Treatments Being Tested
Primary Objectives: * To determine the maximum tolerated dose (MTD) of Top...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2004-08
Trial ID
NCT00502892
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130